Condition
Gastric Atrophy
Total Trials
7
Recruiting
3
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 7 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Recruiting3
Unknown2
Not Yet Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT06370143RecruitingPrimary
A Study Collecting Health Information to Understand and Prevent Gastric Cancer
NCT07060482Not Yet RecruitingPrimary
Gastrin, Anti-helicobacter Pylori and Pepsinogen Diagnostic Accuracy Study
NCT05657080Recruiting
Cytosponge for Gastric Intestinal Metaplasia
NCT05775120UnknownPrimary
Epidemiology of Helicobacter Pylori Infection in Moscow
NCT04843397Unknown
Diagnostic Performance Indicators in Upper GI Endoscopy:PROSPERO Study
NCT03250091Recruiting
Surveillance of Patients With Precancerous Lesions of the Stomach
NCT01824953Completed
Long-term Follow-up Prognosis of Atrophic Gastritis After 3 Years
Showing all 7 trials